Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Century Therapeutics (IPSC) Earnings Date, Estimates & Call Transcripts

Century Therapeutics logo
$2.12 -0.16 (-7.02%)
Closing price 05/19/2026 04:00 PM Eastern
Extended Trading
$2.13 +0.01 (+0.71%)
As of 05/19/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Century Therapeutics Earnings Summary

Century Therapeutics released Q1 2026 earnings on May 13, 2026, reporting an EPS of -$0.11, which topped analysts' consensus estimates of -$0.15 by $0.04. With a trailing EPS of -$1.14, Century Therapeutics' earnings are expected to grow next year, from ($0.62) to ($0.59) per share.

Upcoming Q2
Earnings Date
May. 21Before Market OpensEstimated
Consensus EPS
(May. 13)
-$0.15
Actual EPS
(May. 13)
-$0.11 Beat By $0.04

Q1 2026 Earnings Resources

IPSC Upcoming Earnings

Century Therapeutics' Q1 2026 earnings is estimated for Thursday, May 21, 2026, based on past reporting schedules

Powered by Quartr
Get Century Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Century Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

IPSC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IPSC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Century Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20263-$0.46-$0.20-$0.29
Q2 20263-$0.47-$0.20-$0.29
Q3 20263-$0.47-$0.21-$0.30
Q4 20263-$0.48-$0.21-$0.35
FY 2026 12 -$1.88 -$0.82 -$1.24
Q1 20271-$0.22-$0.22-$0.22
Q2 20271-$0.23-$0.23-$0.23
Q3 20271-$0.22-$0.22-$0.22
Q4 20271-$0.21-$0.21-$0.21

Century Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/21/2026
(Estimated)		--------
5/13/2026Q1 2026-$0.15-$0.11+$0.04-$0.11$2.87M-
3/12/2026Q4 2025-$0.29-$0.25+$0.04-$0.25-$0.08M-
11/13/2025Q3 2025-$0.39-$0.32+$0.07-$0.40--
8/14/2025Q2 2025-$0.38-$0.38--$0.38$0.03M-
5/15/2025Q1 2025-$0.31$0.89+$1.20$0.89$45.52M$109.16M
3/19/2025Q4 2024-$0.45-$0.43+$0.02-$0.43$0.67M$4.18M
11/5/2024Q3 2024-$0.45-$0.37+$0.08-$0.37$0.47M$0.79M
8/8/2024--$0.50-$0.38+$0.12-$0.38$0.55M$0.77M

Data powered by Fiscal.ai.

Century Therapeutics Earnings - Frequently Asked Questions

Century Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 21st, 2026 based off last year's report dates. Learn more on IPSC's earnings history.

In the previous quarter, Century Therapeutics (NASDAQ:IPSC) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.04. Learn more on analysts' earnings estimate vs. IPSC's actual earnings.

Century Therapeutics (NASDAQ:IPSC) has a recorded annual revenue of $109.16 million.

Century Therapeutics (NASDAQ:IPSC) has a recorded net income of -$9.58 million. IPSC has generated -$1.14 earnings per share over the last four quarters.

Century Therapeutics' earnings are expected to grow from ($0.62) per share to ($0.59) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:IPSC) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book attached
Veteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...
Profits Run | Sponsoredtc pixel
The one number Musk can't hide in the S-1
When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...
Behind the Markets | Sponsoredtc pixel
He doesn't buy gold. He just profits from it.
Former hedge fund manager Larry Benedict generated $274 million in profits - and Barron's ranked his fund in t...
Brownstone Research | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel